CORT
Corcept Therapeutics IncCompany with tickers: CORT
CIK
1088856
CUSIP
218352102
Shares Outstanding
107,351,594
13F Activity (30d)
303 filings
300 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $164,903,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $66,265,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $-49,601,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $-31,761,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $-0.30 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |